Brought to you by 
ViewRay's Series D round brings in $17.4mm
05 Jun 2013
Executive Summary
MRI-guided cancer radiotherapy company ViewRay Inc. brought in $17.4mm through the sale of Series D-2 preferred shares to seven unnamed investors. Including the current round and a $10mm debt sale in 2011, the company has raised $101mm from backers including Kearny Venture Partners, OrbiMed Advisors, Fidelity Biosciences, Aisling Capital, and Siemens Venture Capital.
Deal Industry
- Medical Devices
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ViewRay's Series D round brings in $17.4mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice